OpenLB
Open Library of Bioscience
Advanced Search
Clinical and translational medicine
Nov, 2024;14 (11): e70101.

Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model.

Tian Zeng, Xiudi Yang, Yi Wang, Dijiong Wu, Weiying Feng, Ying Lu, Xiaoqiong Zhu, Lirong Liu, Mei Zhou, Li Zhang, Yanping Shao, Honglan Qian, Feng Zhu, Yu Chen, Dan Cao, Li Huang, Xiaoning Feng, Lili Chen, Gang Zhang, Jing Le, Weiguo Zhu, Yongming Xia, Yanxia Han, Yongqing Jia, Guoyan Tian, Hui Zhou, Linjuan Xu, Xiufeng Yin, Qinli Tang, Yuefeng Zhang, Guoli Yao, Xianghua Lang, Kaifeng Zhang, Xiujie Zhou, Junbin Guo, Jinming Tu, Jianzhi Zhao, Gongqiang Wu, Huiqi Zhang, Xiao Wu, Qiulian Luo, Lihong Cao, Binbin Chu, Wei Jiang, Haiying Wu, Liansheng Huang, Meiwei Hu, Muqing He, Jingjing Zhu, Hongyan Tong, Jie Jin, Jian Huang
Author Information
  1. Tian Zeng: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  2. Xiudi Yang: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  3. Yi Wang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  4. Dijiong Wu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  5. Weiying Feng: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  6. Ying Lu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  7. Xiaoqiong Zhu: Zhejiang Clinical Medical Research Center of Hematology, Hangzhou, China.
  8. Lirong Liu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  9. Mei Zhou: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  10. Li Zhang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  11. Yanping Shao: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  12. Honglan Qian: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  13. Feng Zhu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  14. Yu Chen: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  15. Dan Cao: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  16. Li Huang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  17. Xiaoning Feng: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  18. Lili Chen: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  19. Gang Zhang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  20. Jing Le: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  21. Weiguo Zhu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  22. Yongming Xia: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  23. Yanxia Han: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  24. Yongqing Jia: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  25. Guoyan Tian: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  26. Hui Zhou: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  27. Linjuan Xu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  28. Xiufeng Yin: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  29. Qinli Tang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  30. Yuefeng Zhang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  31. Guoli Yao: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  32. Xianghua Lang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  33. Kaifeng Zhang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  34. Xiujie Zhou: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  35. Junbin Guo: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  36. Jinming Tu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  37. Jianzhi Zhao: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  38. Gongqiang Wu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  39. Huiqi Zhang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  40. Xiao Wu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  41. Qiulian Luo: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  42. Lihong Cao: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  43. Binbin Chu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  44. Wei Jiang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  45. Haiying Wu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  46. Liansheng Huang: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  47. Meiwei Hu: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  48. Muqing He: CML Cooperation Group of Zhejiang Hematology, Zhejiang, China.
  49. Jingjing Zhu: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  50. Hongyan Tong: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  51. Jie Jin: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. ORCID
  52. Jian Huang: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. ORCID
PMID: 39576229 DOI: 10.1002/ctm2.70101

Abstract

No abstract text available.

References

  1. Blood. 2013 May 9;121(19):3818-24 [PMID: 23515925]
  2. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e161-e167 [PMID: 38342726]
  3. Blood. 2016 May 19;127(20):2391-405 [PMID: 27069254]
  4. Leukemia. 2003 Dec;17(12):2444-53 [PMID: 14562117]
  5. Haematologica. 2020 Sep 17;105(12):2730-2737 [PMID: 33054104]
  6. Leukemia. 2007 Dec;21(12):2420-7 [PMID: 17805334]
  7. J Hematol Oncol. 2022 Jul 11;15(1):90 [PMID: 35818053]
  8. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):168-176 [PMID: 30504306]
  9. NPJ Digit Med. 2023 May 6;6(1):86 [PMID: 37149704]

Grants

  1. 2022C03137/Key R&D Program of Zhejiang
  2. 2022ZYC-D09/Zhejiang Medical Association Clinical Medical Research Special Fund Project
Letter

Word Cloud

Created with Highcharts 10.0.0Myelofibrosispredictsdeepmolecularresponse45chronicmyeloidleukaemiapatientsinitiallytreatedimatinib:extensivemulticenterretrospectivestudydevelopprognosticmodel

Similar Articles

Cited By

No available data.